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Background: Studies have indicated an important role
for host-derived proteases in the pathogenesis of peri-
odontal disease. The objectives of this study were: 1) to
develop an assay measuring protease activity in situ and
2) to localize and characterize the enzymatic activity in
intact inflamed and healthy gingiva.
Methods: Gingival specimens were prepared and over-
laid with a quenched fluorescent substrate. Protease
activity was visualized by fluorescence microscopy and
correlated with histologic features.
Results: In inflamed tissues, enzymatic activity was
detected mainly in the connective tissue (predominantly
matrix metalloproteases) and, to some extent, in the
epithelium (predominantly serine proteases). In contrast,
clinically healthy tissues failed to exhibit significant
amounts of protease activity. Quantitative and qualitative
characteristics of protease activity in intact tissues were
found to be pH dependent.
Conclusions: The method described here enabled
assessment of active proteases in intact tissues where
cell-cell and cell-matrix interactions had been maintained.
Our results indicate that there are substantial differences
in the distribution of specific proteases between clinically
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H
ost-derived proteases are currently
believed to play a key role in the tissue
destruction associated with many inflam-
matory processes, including rheumatoid arthritis
and the various forms of periodontal disease.1,2
An initiating event in the progression of chronic
periodontal disease is the host immune reaction
to bacterial colonization of the gingival sulcus,
resulting in the recruitment of inflammatory
cells, i.e., neutrophils, macrophages, and lym-
phocytes, to the site of infection.3 In response to
bacterial products and/or host factors, these
cells release proteases which, in turn, partici-
pate in the degradation of the extracellular
matrix (ECM) of the periodontium.2
Early studies demonstrated the presence of
collagenolytic activity in diseased gingival
explants.4,5 Additional investigations delineated
the properties of these collagenases and indi-
cated that the enzymes could be released from
both resident connective tissue and epithelial
cells, as well as infiltrating inflammatory cells.6
More recent studies have attempted to correlate
the levels of protease activity with periodontal
disease severity.7-10 In general, increased levels
of proteolytic activity were detected within gin-
gival crevicular fluid and extracts prepared from
inflamed gingival tissues, when compared to
healthy control samples.
It is currently recognized that members of the
matrix metalloprotease (MMP) family of ECM-
degrading neutral endopeptidases account for
much of the proteolytic activity measured in
sites of gingival inflammation. Specifically, these
include the gelatinases (MMPs-2 and -9),9
stromelysin (MMP-3),1,9 and the collagenases
(MMPs-1, -8, and -13).10,11 These overall obser-
vations suggest that activated MMPs are major
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participants in the destruction of connective tissues,
which is a hallmark of periodontitis.
In situ, protease activity is regulated in a hierarchi-
cal fashion:1 1) at the transcriptional level where pro-
tease gene expression can be altered in response to
specific inflammatory mediators and cytokines;12 2)
at the translational level where proteases are synthe-
sized as latent forms requiring processing for conver-
sion into their active proforms;13 3) by sequestration
in secretory vesicles such as the azurophilic granules
in neutrophils;14 and 4) by the presence of endoge-
nous inhibitors such as the tissue inhibitors of metal-
loproteinases (TIMPs).15,16 The regulatory mecha-
nisms within intact tissues have made it difficult to
identify activated proteases using conventional bio-
chemical techniques.17 Furthermore, the alternative
approach of in situ immunohistochemistry does not
discern between latent and active forms, nor does it
reflect the presence of endogenous protease inhibitors.
Therefore, the goal of the current study was to develop
a technique which would identify and localize acti-
vated proteases within intact healthy and diseased
periodontal tissues. Our results demonstrate the pres-
ence of activated MMPs and serine proteases in
inflamed gingiva, and indicate that these enzymes are
differentially distributed between the connective tissue
and epithelial compartments of the periodontium.
MATERIALS AND METHODS
Tissue Specimens
Gingival tissue samples were obtained from patients
attending the dental clinics within the University of
Pennsylvania (Graduate Periodontics Clinic at the
School of Dental Medicine and the Department of
Oral and Maxillofacial Surgery of the University of
Pennsylvania Medical Center) and Dental Service,
Veterans Affairs Medical Center (Philadelphia). Twelve
patients participated in the study: 6 patients in the
diseased group ranging in age from 26 to 52 years
(average 36.3 ± 9.8 SD); and 6 in the control group
(i.e., clinically healthy tissues) with ages ranging from
36 to 52 years (average 44.7 ± 7.8 SD). The protocol
was approved by the Institutional Review Board of the
University of Pennsylvania.
All patients participating in the study were physi-
cally healthy and none had received prescribed anti-
biotics or anti-inflammatory medications in the 
6 months prior to their periodontal surgery. Patients
were diagnosed with chronic adult periodontal disease
based on visual signs of inflammation,18 probing
depths ≥5 mm, and bleeding upon probing at the base
of the pockets.19,20 Tissues removed at surgical
pocket elimination comprised the clinically inflamed
specimens. Non-inflamed specimens (absence of
visual signs of inflammation, probing depth ≤3 mm,
and absence of bleeding upon probing at the base of
the pocket) were obtained from patients undergoing
crown lengthening procedures.
Tissue Protease Activity and Histologic Mapping
Tissue specimens for in situ zymography were ori-
ented, using a horizontal reference incision made prior
to tissue removal, to allow visualization of pocket and
oral epithelium within the same section.21,22 Samples
were embedded in tissue freezing medium without fix-
ation, and stored at −80°C. For analysis, 6 µm sec-
tions were cut at −16°C and immediately overlaid with
the substrate BODIPY TR-X labeled β-casein¶
(4 mg/ml in 10mM Tris, pH 6, 7, or 7.8), coverslipped,
and incubated in a dark humidified chamber at 37°C
for 3 hours. This assay is based on the principle that
substrate fluorescence is quenched in its native form
and, upon cleavage by proteases, the quenched sub-
strate becomes fluorescent (Fig. 1).23 Areas of prote-
olytic activity are readily visible as discrete regions of
fluorescence.
Sections were photographed at 400x magnification
and digitized with a slide scanner.# To account for
background activity, a fluorescence threshold was
established by viewing duplicate overlaid sections
before incubation. This was subtracted from the
brightness of the final digitized image to determine
the fluorescence resulting from enzymatic cleavage of
the substrate. Serial sections of each sample under-
went a specific treatment. The effect of pH on enzy-
matic activity within healthy and diseased gingival
tissues was evaluated by incubating tissue sections at
pH 6.0, 7.0, or 7.8. For each pH, 3 sections were ana-
lyzed, each under a different condition. The first sec-
tion was incubated in buffer without inhibitor; the
second in buffer containing a serine protease
inhibitor;24** and the third containing ethylenedi-
aminetetraacetic (EDTA, an MMP inhibitor).1†† These
inhibitors were used to allow identification of the
active proteases. Alternate sections were fixed in 4%
Figure 1.
Protease-catalyzed hydrolysis relieves the fluorescence-quenching of
BODIPY TR-X labeled ß-casein.As illustrated in the schematic, the
fluorescence of the native molecule is quenched due to the molecular
configuration of the molecule. Following proteolytic cleavage, the
quenching is relieved and the magnitude of resultant fluorescence is
proportional to the extent of proteolytic digestion.
¶ Molecular Probes Inc., Eugene, OR.
# Nikon LS-2000, Nikon Inc., Melville, NY.
** Bowman Birk Inhibitor, Sigma Chemical Co., St. Louis, MO.
†† Sigma Chemical Co.
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formalin and stained with hematoxylin and eosin (H &
E) to enable a direct comparison of protease activity
with tissue histology. Once digitized, the H & E
stained section (Fig. 2A) was overlaid with the fluo-
rescent image (Fig. 2B) for histologic localization and
mapping of enzymatic activity. Areas of proteolysis
were evident as white regions in the photomicro-
graphs (Fig. 2C).
Quantitative Analysis of Protease Activity
The quantitation of protease activity was done using
fluorescence polarization methods. Specifically, tissue
extracts were prepared from the same samples that
had been utilized for in situ analysis by homogeniza-
tion in PBS using a polytron homogenizer. The extracts
were centrifuged (10,000 × 10 minutes, 4°C) and the
protein concentration of the resultant supernatants was
assessed with a protein assay‡‡ using bovine serum
albumin as a standard. The supernatants were ali-
quoted and stored at −20°C. For each sample, an
aliquot was designated to undergo a specific treatment.
Fluoresceinated substrate¶ was used at a final concen-
tration of 10 µg/ml in buffers of pH 6.0, 7.0, or 7.8, in
the presence or absence of an inhibitor: phenylmethyl-
sulfonyl fluoride (PMSF),†† a serine protease inhibitor25
(5 mM), or EDTA†† (20 mM). These inhibitors were
included in the substrate buffers to facilitate identifica-
tion of the active enzymes. Extracts were thawed,
mixed with substrate, and incubated for 3 hours after
which fluorescence analysis was performed with a fluo-
rometer§§ set up at excitation/emission maxima of
595/615 nm, respectively. Each extract was analyzed
at 3 protein concentrations. Duplicate measurements
were taken and mean fluorescence values were calcu-
lated. Results were expressed as fluorescent ratios,
with the disease group set at 1 (unit).
To generate a standard reference curve, BODIPY XT-
labeled casein was incubated with increasing concen-
trations of purified trypsin.†† The resultant fluorescence
was measured and expressed as absolute fluorescent
values. In the region from 0 to 3 µg/ml of the standard
reference curve, a direct correlation between fluores-
cence and trypsin concentration was observed (Fig. 3).
This correlation was utilized to estimate the quantity of
active proteases present in individual samples.
Data Management and Analysis
Each patient contributed a single tissue sample,
which served as the experimental unit of analysis. The
individual fluorescence value in vitro, for each of the
measured parameters, was arranged by group (either
healthy or inflamed), and a mean ± SD was calcu-
lated. The null hypothesis of no difference in recorded
fluorescent levels between two groups was tested for
each comparison, using Student t tests and Wilcoxon
rank sum tests (Table 1). Sample size was established
based upon an initial analysis of 3 samples from each
group and designed to obtain alpha (Type I error)
<0.05, with beta (Type II error) set at 0.20. The
results of this analysis indicated that a sample size of
6 for each group would identify a significant differ-
ence if one existed.
RESULTS
In Situ Protease Activity and Histologic Mapping
When inflamed tissue sections were evaluated at 
pH 7.8, protease activity was detected predominantly
within the connective tissue (Fig. 2C). This activity
was inhibited in the presence of EDTA, an MMP
inhibitor (Fig. 2D versus Fig. 2C). Interestingly, when
tissue sections were incubated at pH 6.0, the enzymatic
activity was localized to the epithelium (Fig. 2E). This
activity was not inhibited by EDTA but was suppressed
by BBI, an inhibitor of serine proteases (Fig. 2F ver-
sus 2E). These results indicated that MMPs were the
major form of activated proteases within the inflamed
gingival tissue samples. Additionally, serine proteases
were active within the epithelial compartment of these
tissues at lower pH.
Little proteolytic activity was detected within
epithelia or connective tissues of healthy samples,
despite the presence of inflammatory cells (Fig. 4). In
contrast, maximal protease activity within the con-
nective tissues of inflamed samples was detected at
pH 7.8. This activity was localized to areas of intense
inflammatory cell infiltration. The magnitude of con-
nective tissue protease activity appeared to be pH
dependent, as samples incubated at pH 6.0 and 7.0
exhibited significantly less fluorescence when com-
pared to sections incubated at pH 7.8. At the lower
pHs, increasing amounts of epithelial protease activity
were detected. In contrast to healthy sections, this
activity was distributed throughout the epithelia of the
inflamed samples (Fig. 4).
Quantitative Analysis of Protease Activity
Incubation of healthy and inflamed tissue extracts
with substrate at pH 7.8 yielded a protease level of
0.13 µg/ml and 0.45 µg/ml trypsin equivalents,
respectively. Comparison between the average pro-
tease activity contained in extracts prepared from dis-
eased versus healthy tissues showed that diseased
samples contained higher levels of proteolytic activity
than controls (1.0 units ± 0.05 versus 0.81 units ±
0.02, respectively, Table 1) (Fig. 5).
PMSF, a serine protease inhibitor, reduced the enzy-
matic activity by 29% (1.0 units ± 0.05 versus 0.82
units ± 0.02). The decrease was statistically significant
(Table 1, Fig. 6). The activity was significantly inhib-
ited to an even greater extent with EDTA (75%), a
metalloprotease inhibitor (1.0 units ± 0.05 versus 0.54
‡‡ Bio-Rad Laboratories, Hercules, CA.
§§ PTI Alphascan, Photon Technology International, South Brunswick, NJ.
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Figure 2.
Localization and characterization of protease activity in inflamed gingiva.The serial sections shown in Panels A through F were prepared from the same
tissue sample. Panel A contains a transverse section stained with hematoxylin and eosin allowing identification of the gingival epithelial (e) and
connective tissue (ct) compartments. Panel B is composed of a fluorescence micrograph of a serial section incubated with BODIPY TR-X labeled casein
at pH 7.8. In situ proteolytic activity appears as white areas (Panels B-F).The images in Panels A and B were overlaid to generate Panel C. Protease
activity is present in the connective tissue but not in the epithelium (arrows). Panel D demonstrates decreased protease activity in the presence of
EDTA, an MMP inhibitor (pH 7.8).The section shown in Panel E was evaluated at pH 6.0 in the presence of EDTA and demonstrates enzymatic
activity in the epithelium.Addition of BBI, a serine protease inhibitor, blocked the proteolytic activity detected within the epithelium (Panel F).
visible by standard fluorescent microscopy and does
not interfere with the green autofluorescence of elastin.
This approach enabled us to evaluate protease activity
in intact periodontal sections, where cell-cell and cell-
ECM relationships have been maintained.
The histologic evaluation indicated that protease
activity was increased in both the connective tissue
and the epithelium of inflamed samples. The magni-
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Figure 3.
Fluorescence resulting from cleavage of BODIPY TR-X labeled casein by
trypsin.A standard reference curve was generated by measuring the
fluorescence resulting from incubation of BODIPY TR-X labeled casein
with increasing concentrations of purified trypsin (3 hours at 37°C, pH
7.8). Fluorescence was plotted as units of fluorescence (× 103). Note
the sensitivity of the substrate and the linear response from 0 to 3
µg/ml of trypsin (r2 = 0.98).
units ± 0.03; Table 1). The level of inhibition achieved
by EDTA was significantly greater than that seen with
PMSF (pt test <0.0001, pWilcoxon = 0.005) (Fig. 6).
The highest level of in vitro protease activity was
observed at pH 7.8 (Fig. 7). Slightly less activity was
measured at pH 7.0 (1.0 units ± 0.05 versus 0.95
units ± 0.07 [pt test >0.5, pWilcoxon = 0.57]). Relative
to pH 7.8, the activity detected at pH 6.0 was signifi-
cantly decreased (1.0 units ± 0.05 versus 0.75 units ±
0.04 [pt test <0.03, pWilcoxon = 0.005]) (Fig. 7). These
observations were in agreement with our findings in
situ.
DISCUSSION
In the current paradigm of periodontal pathogenesis,
host-derived MMPs are believed to play a major role in
mediating destruction of the extracellular matrix (ECM).
This is based on studies which have shown increased
levels of MMPs in gingival crevicular fluid8,26-28 and
extracts prepared from diseased periodontal tis-
sues.5-7,9,29 It is established that regulation of prote-
olytic activity in situ is a complex phenomenon that
may not be adequately replicated when evaluated by
currently available in vitro assays. Therefore, the goal
of the current study was 2-fold: 1) to develop an assay
to measure protease activity
in situ and 2) to use this
technology to characterize
the enzymatic activity within
intact gingiva. Our findings
further support the concept
of MMP involvement in the
periodontal pathogenic pro-
cess, and also indicate a po-
tential role for serine pro-
teases in this process.
Protease activity in situ
was evaluated using a modi-
fication of the technique
previously described by
Galis et al.30 To our knowl-
edge, their report is the only
one addressing in situ detec-
tion of active proteases. The
BODIPY TR-X-labeled β-
casein substrate used for our
analyses has several advan-
tages over those used previ-
ously. Firstly, non-fluorescing substrate does not have
to be washed away prior to analysis, allowing evalua-
tion of unfixed tissue specimens. In addition, fluores-
cence of the substrate occurs independently of pH and
allows for modification of buffer pH without impairing
the fluorescence response.31 As a result, tissue sec-
tions or extracts can be examined to determine the
effect of pH on protease activity. Finally, the red dye is
Table 1.
Statistical Analysis of Protease Activity in Clinically Healthy 
and Diseased Tissues
t-Test Wilcoxon Test
(Comparison to (Comparison to
Mean Median SD Range Diseased Group) Diseased Group)
Disease 1.0 0.99 0.13 0.85-1.16
Healthy 0.81 0.81 0.04 0.74-0.85 P <0.01* P = 0.004* 
(z = −2.642)
Disease + PMSF 0.82 0.82 0.05 0.77-0.89 P <0.02† P = 0.01†
(z = −2.322)
Disease + EDTA 0.54 0.54 0.07 0.45-0.64 P <0.00007‡ P = 0.0025‡
(z = −2.802)
* Healthy group versus diseased group.
† Disease and PMSF (inhibitor of serine proteases) group versus diseased group.
‡ Disease and EDTA (inhibitor of metalloproteases) group versus diseased group.
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Figure 4.
The quantitative and qualitative characteristics of in situ protease activity are pH dependent. Serial sections prepared from clinically healthy or inflamed
gingival samples were evaluated for in situ detection of protease activity (seen as white areas overlaid on H & E sections) at varying pH. In sections
prepared from non-inflamed gingiva, note that protease activity was absent under all pH conditions despite the presence of inflammatory cells. In
inflamed gingiva, protease activity was detected in the oral and pocket epithelia when evaluated at pH 6.0.The epithelial protease activity diminished in
magnitude at pH 7.0 and 7.8. In contrast, connective tissue protease activity was maximal at pH 7.0 and 7.8.
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tude of proteolytic activity within the connective tissues
of these samples was highly dependent on buffer pH.
At physiologic pH, a majority of the activity was attrib-
utable to MMPs. As would be expected, the most
intense levels of protease activity were observed in the
vicinity of inflammatory cells within the connective tis-
sue subjacent to the periodontal pocket. In contrast,
the epithelium of these tissues and all compartments of
control samples were free of activated MMPs. These
findings are consistent with those of Woolley and
Davies29 who utilized immunohistochemistry to
demonstrate the presence of collagenase activity that
was specifically localized to nests of inflammatory cells
within the connective tissue of diseased samples. The
results of our study are also compatible with those of
Ingman et al.32,33 and Westerlund et al.,34 who showed
increased levels of MMPs (-1, -3, and -8) and gelati-
nases (MMP-9 and another gelatinase [neutrophil
gelatinase-associated lipocain, NGAL]) in inflamed
gingival connective tissues, respectively. Taken
together, these results strongly suggest that metallo-
proteases may play an important role in the connective
tissue breakdown associated with periodontal disease.
Analysis of H & E stained sections prepared from
clinically healthy control specimens allowed for identi-
fication of inflammatory cells, which can be a major
source of proteases.35 Interestingly, we did not detect
significant amounts of activated proteases in healthy
tissue sections, despite the presence of inflammatory
cells. Modest inflammatory cell infiltration of the clini-
cally healthy periodontium is thought to represent a
chronic reaction to constant bacterial challenge.36,37 In
healthy tissues, the absence of activated MMPs may be
due to numerous mechanisms including: 1) cytokine-
mediated inhibition of protease synthesis by inflamma-
tory cells;38 2) absence of factors required for
activation of latent proteases;13,39,40 and/or 3) high
levels of specific MMP inhibitors (TIMPs).41,42
In addition to infiltrating inflammatory cells, resident
cells within the gingiva may also serve as a source of
MMPs. In vitro studies have suggested that gingival
Figure 5.
Extracts prepared from healthy (n = 6) and inflamed (n = 6) gingival
tissue samples were evaluated individually for protease activity. For
comparison, fluorescence ratios were expressed, with the mean value of
inflamed tissue samples established as a unit (1 ± 0.05 SD). Mean
activity of clinically healthy tissues was significantly decreased (0.81 ±
0.02 SD; P <0.01). Note the clustered distribution of the samples within
each group.
Figure 7.
The magnitude of in vitro protease activity is pH dependent. Extracts
prepared from inflamed gingival tissues (n = 6) were incubated with
BODIPY TR-X labeled casein at various pH (3 hours at 37°C).
Fluorescence was determined and plotted as units of fluorescence 
(× 103). Maximal protease activity was observed at pH 7.8.There was
no significant difference between the enzymatic activity measured at
pH 7. 0 versus 7.8. However, when evaluated at pH 6.0, the samples
exhibited significantly less protease activity (1.0 units ± 0.05 versus
0.75 units ± 0.04; P <0.03).
Figure 6.
MMPs were the predominant form of active proteases in extracts
prepared from inflamed gingival tissues.The identification of activated
proteases in tissue extracts (n = 6) was determined by incubating
samples with BODIPY TR-X labeled casein in the presence of specific
protease inhibitors (3 hours at 37°C, pH 7.8). Fluorescence was
determined and plotted as units of fluorescence (× 103). PMSF, a serine
protease inhibitor, suppressed the overall activity by 29% (1.0 units 
± 0.05 versus 0.82 units ± 0.02; P <0.02). EDTA, an MMP inhibitor,
suppressed the activity by 75% (1.0 units ± 0.05 versus 0.54 units 
± 0.03; P <0.00007).
epithelial cells are capable of synthesizing ECM-
degrading proteases.16,43 Meikle et al.16 used immuno-
localization to identify collagenase in the epithelium of
cultured explants. Reynolds and Hembry43 detected
collagenase and stromelysin-1 within the epithelium of
cultured periodontal tissues. In the current study, we
have confirmed and extended these observations by
demonstrating the presence of activated serine pro-
teases within non-manipulated inflamed gingival
epithelium. Previously, serine proteases have been
localized in periodontal tissues, using immuno-
histochemical studies. In contrast to our results,
Tervahartiala et al.44 detected cathepsin G in GCF and
in lamina propria beneath the sulcular epithelia only.
However, cathepsin G45,46 and medullasin46 had also
been found in connective tissues and pocket epithelia
from periodontal patients. Our results indicate that
epithelially derived active proteases reported by other
groups are not an artifact of tissue culture.
The in vitro evaluation of tissue extracts via fluo-
rometry showed significantly greater levels of pro-
tease activity in extracts prepared from diseased
tissues compared to healthy control samples. By
comparing the fluorescence resulting from tissue
extracts to that induced by known concentrations of
trypsin, we were able to estimate the quantity of enzy-
matic activity contained within each sample. The total
concentration of active protease in extracts prepared
from diseased samples was equivalent to 0.45 µg/ml
of trypsin activity. This value is similar to the estimate
of Birkedal-Hansen47 who reported the metallopro-
tease concentration of inflamed tissue extracts in the
range of 1 µg/ml. Although metalloproteases were the
predominant form of proteolytic enzymes within
inflamed samples, 29% of the total activity was due to
serine proteases. Since the epithelium and connective
tissues were not separated prior to preparation of tis-
sues extracts, these values could represent the distri-
bution of MMPs and serine proteases within the 
2 tissue compartments.
Protease activity is regulated in situ at multiple lev-
els involving transcriptional, translational, and post-
translational mechanisms.1,11-14 Since these enzymes
have optimal pHs at which they are active, it is rea-
sonable to hypothesize that tissue pH may serve as
an additional mechanism of protease regulation.
While it has been shown that gingival crevicular fluid
pH seems to shift from acid to basic as periodontal
disease progresses,48-50 little is known about the local
pH of inflamed gingival epithelium or connective tis-
sues, and the impact of tissue pH on protease activity
has rarely been addressed.51 Our results demon-
strated maximal connective tissue MMP activity when
samples were incubated at pH 7.8. At lower pH, pro-
teolytic activity within the connective tissues dimin-
ished and the magnitude of activity seen in the
epithelium increased. Furthermore, a majority of the
activity seen in the epithelium appears to be attribut-
able to serine proteases. Thus, local pH may affect
both the quantitative and qualitative characteristics of
protease activity in situ.
The aim of the current study was to extend our
knowledge regarding the potential role of host-derived
proteases in the pathogenesis of periodontal disease.
Our results suggest that specific types of active pro-
teases are present in different tissue compartments
(i.e., epithelium and connective tissue). These findings
support a role for MMPs in the degradation of inflamed
gingival connective tissues, as well as a role for serine
proteases, present in the gingival epithelium. The
activities of these enzymes are pH dependent, indicat-
ing that local pH could represent an additional mecha-
nism regulating protease activity in situ. Further
studies are needed to clarify the mechanisms regulat-
ing protease activity in tissue and the role that these
enzymes play in periodontal breakdown.
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